| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $73.2M | +62.9% |
| SG&A Expense | $13.8M | +17.0% |
| Operating Income | -$87.0M | -53.3% |
| Interest Expense | $54K | +0.0% |
| Pre-tax Income | -$81.4M | -49.5% |
| Income Tax | $147K | +0.0% |
| Net Income | -$81.4M | -49.1% |
| EPS (Basic) | -$3.98 | -729.2% |
| EPS (Diluted) | -$3.98 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $70.6M | +7.9% |
| Current Assets | $71.6M | +5.4% |
| Total Assets | $72.8M | +3.5% |
| Current Liabilities | $12.7M | +13.0% |
| Total Liabilities | $12.7M | +10.4% |
| Stockholders' Equity | $60.1M | +2.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$43.8M | +10.8% |
| Investing Cash Flow | $49.0M | — |
| Financing Cash Flow | -$30K | +85.7% |
| -729.2% |